Emerging therapies for patients with advanced chronic lymphocytic leukaemia

This publication has 87 references indexed in Scilit:

• Genomic Aberrations, VH Mutation Status and Outcome after Fludarabine and Cyclophosphamide (FC) or FC Plus Rituximab (FCR) in the CLL8 Trial
  Blood, 2008
• New prognostic markers in chronic lymphocytic leukemia
  Blood Reviews, 2008
• Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
  Blood, 2008
• Controversies in the front-line management of chronic lymphocytic leukemia
  Leukemia Research, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
  The Lancet, 2007
• Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997
  Journal of Clinical Oncology, 2007
• Chlorambucil in Indolent Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 1998
• A clinical staging system for chronic lymphocytic leukemia.Prognostic significance
  Cancer, 1977
• Clinical staging of chronic lymphocytic leukemia
  Blood, 1975